These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 27554132)

  • 1. Relationship between serum betatrophin levels and the first-phase of glucose-stimulated insulin secretion.
    Liu D; Qu H; Wang H; Duan Y; Liu F; Feng Z; Deng H
    Obes Res Clin Pract; 2018; 12(Suppl 2):9-15. PubMed ID: 27554132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating Betatrophin Correlates with Triglycerides and Postprandial Glucose among Different Glucose Tolerance Statuses--A Case-Control Study.
    Gao T; Jin K; Chen P; Jin H; Yang L; Xie X; Yang M; Hu C; Yu X
    PLoS One; 2015; 10(8):e0133640. PubMed ID: 26247824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between serum secreted frizzled-related protein 4 levels and the first-phase of glucose-stimulated insulin secretion in individuals with different glucose tolerance.
    Liu F; Qu H; Li Y; Tang Q; Yang Z; Wang H; Deng H
    Endocr J; 2015; 62(8):733-40. PubMed ID: 26041556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating betatrophin levels are increased in patients with type 2 diabetes and associated with insulin resistance.
    Chen X; Lu P; He W; Zhang J; Liu L; Yang Y; Liu Z; Xie J; Shao S; Du T; Su X; Zhou X; Hu S; Yuan G; Zhang M; Zhang H; Liu L; Wang D; Yu X
    J Clin Endocrinol Metab; 2015 Jan; 100(1):E96-100. PubMed ID: 25303484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased circulating levels of betatrophin in newly diagnosed type 2 diabetic patients.
    Hu H; Sun W; Yu S; Hong X; Qian W; Tang B; Wang D; Yang L; Wang J; Mao C; Zhou L; Yuan G
    Diabetes Care; 2014 Oct; 37(10):2718-22. PubMed ID: 25024395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of islet beta cell function in subjects with normal glucose tolerance, impaired glucose regulation, and type 2 diabetes mellitus].
    Liu J; Li YB; Shao H; Li YX; Yuan YH; Xiao YB; Weng JP
    Zhonghua Yi Xue Za Zhi; 2007 May; 87(18):1252-5. PubMed ID: 17686259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.
    Henkel E; Menschikowski M; Koehler C; Leonhardt W; Hanefeld M
    Metabolism; 2005 Sep; 54(9):1168-73. PubMed ID: 16125528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum betatrophin concentrations are significantly increased in overweight but not in obese or type 2 diabetic individuals.
    Guo K; Lu J; Yu H; Zhao F; Pan P; Zhang L; Chen H; Bao Y; Jia W
    Obesity (Silver Spring); 2015 Apr; 23(4):793-7. PubMed ID: 25776943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma Betatrophin Levels of Subjects Classified with Normal, Impaired, and Diabetic Glucose Tolerance, and Subjects with Impaired Fasting Glucose.
    Ozyazgan S; Onal B; Kurtulus EM; Uzun H; Akkan G; Konukoglu D
    Horm Metab Res; 2017 Jun; 49(6):434-439. PubMed ID: 28351091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating Levels of Betatrophin and Irisin Are Not Associated with Pancreatic β-Cell Function in Previously Diagnosed Type 2 Diabetes Mellitus Patients.
    Wang L; Song J; Wang C; Lin P; Liang K; Sun Y; He T; Li W; Zhao R; Qin J; Lu Y; Liu J; Liu F; Hou X; Chen L
    J Diabetes Res; 2016; 2016():2616539. PubMed ID: 26649318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose Homeostatic Law: Insulin Clearance Predicts the Progression of Glucose Intolerance in Humans.
    Ohashi K; Komada H; Uda S; Kubota H; Iwaki T; Fukuzawa H; Komori Y; Fujii M; Toyoshima Y; Sakaguchi K; Ogawa W; Kuroda S
    PLoS One; 2015; 10(12):e0143880. PubMed ID: 26623647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of betatrophin with youth onset type 2 diabetes among Asian Indians.
    Gokulakrishnan K; Manokaran K; Pandey GK; Amutha A; Ranjani H; Anjana RM; Mohan V
    Diabetes Res Clin Pract; 2015 Jul; 109(1):71-6. PubMed ID: 25981323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating betatrophin concentrations are decreased in human obesity and type 2 diabetes.
    Gómez-Ambrosi J; Pascual E; Catalán V; Rodríguez A; Ramírez B; Silva C; Gil MJ; Salvador J; Frühbeck G
    J Clin Endocrinol Metab; 2014 Oct; 99(10):E2004-9. PubMed ID: 25050901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between serum adipsin and the first phase of glucose-stimulated insulin secretion in individuals with different glucose tolerance.
    Zhou Q; Ge Q; Ding Y; Qu H; Wei H; Wu R; Yao L; Wei Q; Feng Z; Long J; Deng H
    J Diabetes Investig; 2018 Sep; 9(5):1128-1134. PubMed ID: 29432659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased serum levels of betatrophin in pancreatic cancer-associated diabetes.
    Susanto H; Liu TY; Chen CC; Purnomo JD; Chen SF; Wang CH
    Oncotarget; 2016 Jul; 7(27):42330-42339. PubMed ID: 27276680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Betatrophin: no relation to glucose metabolism or weight status in obese children before and after lifestyle intervention.
    Roth CL; Elfers C; Lass N; Reinehr T
    Pediatr Diabetes; 2017 Sep; 18(6):485-491. PubMed ID: 27402552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating betatrophin in healthy control and type 2 diabetic subjects and its association with metabolic parameters.
    Al-Daghri NM; Rahman S; Sabico S; Amer OE; Wani K; Ansari MG; Al-Attas OS; Kumar S; Alokail MS
    J Diabetes Complications; 2016; 30(7):1321-5. PubMed ID: 27311786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired secretion of glucagon-like peptide 1 during oral glucose tolerance test in patients with newly diagnosed type 2 diabetes mellitus.
    Wang XL; Ye F; Li J; Zhu LY; Feng G; Chang XY; Sun K
    Saudi Med J; 2016 Jan; 37(1):48-54. PubMed ID: 26739974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of future diabetes is as high with abnormal intermediate post-glucose response as with impaired glucose tolerance.
    Viswanathan V; Clementina M; Nair BM; Satyavani K
    J Assoc Physicians India; 2007 Dec; 55():833-7. PubMed ID: 18405128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma adiponectin levels in high risk African-Americans with normal glucose tolerance, impaired glucose tolerance, and type 2 diabetes.
    Osei K; Gaillard T; Schuster D
    Obes Res; 2005 Jan; 13(1):179-85. PubMed ID: 15761178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.